Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2012 Jun 06;3223:7941-8. doi: 10.1523/JNEUROSCI.0158-12.2012.
Show Gene links
Show Anatomy links
Acetylcholine receptor gating in a zebrafish model for slow-channel syndrome.
Walogorsky M
,
Mongeon R
,
Wen H
,
Mandel G
,
Brehm P
.
Abstract
Slow-channel syndrome (SCS) is an autosomal-dominant disease resulting from mutations in muscle acetylcholine (ACh) receptor subunits. The associated fatigue and muscle degeneration are proposed to result from prolonged synaptic responses that overload intracellular calcium. Single-channel studies on reconstituted receptors bearing human mutations indicate that the prolonged responses result from an increase in receptor open duration and, in some cases, increased sensitivity to ACh. We show that both of these aberrant receptor properties are recapitulated in heterozygotic zebrafish bearing an L258P mutation in the α subunit, thus affording the unique opportunity to compare the single-channel properties of mutant receptors to the synaptic currents in vivo. Whole-cell recordings revealed synaptic currents that decayed along a multiexponential time course, reflecting receptors containing mixtures of wild-type and mutant α subunits. Treatment with quinidine, an open-channel blocker used to treat the human disorder, restored fast synaptic current kinetics and the ability to swim. Quinidine block also revealed that mutant receptors generate a large steady-state current in the absence of ACh. The spontaneous openings reflected a destabilization of the closed state, leading to an apparent increase in the sensitivity of these receptors to ACh. The effective block by quinidine on synaptic currents as well as nonliganded openings points to dual sources for the calcium-dependent myopathy in certain forms of SCS.
Auerbach,
The gating isomerization of neuromuscular acetylcholine receptors.
2010, Pubmed
Auerbach,
The gating isomerization of neuromuscular acetylcholine receptors.
2010,
Pubmed
Burgess,
Modulation of locomotor activity in larval zebrafish during light adaptation.
2007,
Pubmed
Colquhoun,
On the stochastic properties of bursts of single ion channel openings and of clusters of bursts.
1982,
Pubmed
Drapeau,
Limits to the development of fast neuromuscular transmission in zebrafish.
2001,
Pubmed
Engel,
A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel.
1982,
Pubmed
Engel,
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome.
1996,
Pubmed
Engel,
End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit.
1996,
Pubmed
Engel,
Myasthenic syndromes attributed to mutations affecting the epsilon subunit of the acetylcholine receptor.
1993,
Pubmed
Fukudome,
AChR channel blockade by quinidine sulfate reduces channel open duration in the slow-channel congenital myasthenic syndrome.
1998,
Pubmed
Gomez,
Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome.
2002,
Pubmed
,
Xenbase
Gomez,
A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome.
1996,
Pubmed
Gomez,
Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.
1997,
Pubmed
,
Xenbase
Grosman,
Kinetic, mechanistic, and structural aspects of unliganded gating of acetylcholine receptor channels: a single-channel study of second transmembrane segment 12' mutants.
2000,
Pubmed
Harper,
Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome.
1998,
Pubmed
Hoffmann,
Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit.
2006,
Pubmed
Jackson,
Kinetics of unliganded acetylcholine receptor channel gating.
1986,
Pubmed
Jackson,
Spontaneous openings of the acetylcholine receptor channel.
1984,
Pubmed
Jadey,
Design and control of acetylcholine receptor conformational change.
2011,
Pubmed
Kullberg,
Contribution of cholinesterase to developmental decreases in the time course of synaptic potentials at an amphibian neuromuscular junction.
1980,
Pubmed
,
Xenbase
Lefebvre,
Increased neuromuscular activity causes axonal defects and muscular degeneration.
2004,
Pubmed
Leonard,
Agonist-induced myopathy at the neuromuscular junction is mediated by calcium.
1979,
Pubmed
Leonard,
Calcium-mediated myopathy at neuromuscular junctions of normal and dystrophic muscle.
1982,
Pubmed
Milone,
Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit.
1997,
Pubmed
Mongeon,
An acetylcholine receptor lacking both γ and ε subunits mediates transmission in zebrafish slow muscle synapses.
2011,
Pubmed
,
Xenbase
Nguyen,
Maturation of neuromuscular transmission during early development in zebrafish.
1999,
Pubmed
Ohno,
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit.
1995,
Pubmed
Paradiso,
Long-term desensitization of nicotinic acetylcholine receptors is regulated via protein kinase A-mediated phosphorylation.
1998,
Pubmed
,
Xenbase
Purohit,
Unliganded gating of acetylcholine receptor channels.
2009,
Pubmed
Sine,
Activation of acetylcholine receptors on clonal mammalian BC3H-1 cells by low concentrations of agonist.
1986,
Pubmed
Sine,
Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity.
1995,
Pubmed
Wen,
Paired motor neuron-muscle recordings in zebrafish test the receptor blockade model for shaping synaptic current.
2005,
Pubmed
Zhou,
Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes.
1999,
Pubmed
